- Previous Close
0.4400 - Open
0.4350 - Bid 0.4300 x --
- Ask 0.4450 x --
- Day's Range
0.4300 - 0.4450 - 52 Week Range
0.4300 - 0.6750 - Volume
172,200 - Avg. Volume
87,371 - Market Cap (intraday)
166.39M - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
22.25 - EPS (TTM)
0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.66
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It offers HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and products such as hospital furniture, life-support solution, MR compatible monitoring solution, oxygen therapy and suction solution, patient monitoring system, resuscitation care, ultrasound solution, women and childcare, critical care solution, and anaesthesia solution. In addition, the company provides services, including clinical training on equipment, planned preventive maintenance, installations, equipment pre-checks, equipment servicing and repair, 24/7 emergency call-out, unlimited break down call, and spare parts procurement. The company was formerly known as UMediC Group Sdn Bhd and changed its name to UMediC Group Berhad in September 2021. UMediC Group Berhad was incorporated in 2021 and is headquartered in Penang, Malaysia. UMediC Group Berhad is a subsidiary of UMediC Capital Sdn Bhd.
www.umedic.com.myRecent News: 0256.KL
View MorePerformance Overview: 0256.KL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0256.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0256.KL
View MoreValuation Measures
Market Cap
166.39M
Enterprise Value
150.84M
Trailing P/E
19.96
Forward P/E
18.55
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.25
Price/Book (mrq)
2.20
Enterprise Value/Revenue
2.95
Enterprise Value/EBITDA
11.04
Financial Highlights
Profitability and Income Statement
Profit Margin
16.32%
Return on Assets (ttm)
7.19%
Return on Equity (ttm)
11.67%
Revenue (ttm)
51.2M
Net Income Avi to Common (ttm)
8.36M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
16.1M
Total Debt/Equity (mrq)
0.72%
Levered Free Cash Flow (ttm)
-3.07M